In the same study, they raised questions about a dysregulation mechanism of the beta-catenin E-cadherin complex in this MN BCC because of the nuclear location of the beta-catenin expression in this subtype [39]. The gene discussed is CDH1; the disease is skin basal cell carcinoma.